Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20190802001Phase 2Recruiting
Phase 2, randomised, open-label trial in corpus luteum cyst (2 arms), sponsored by Mahidol University. Primary endpoints: Incidence of corpus luteal cyst at 2 weeks after oocyte retrieval and Incidence of corpus luteal cyst at 4 weeks after oocyte retrieval. Started Oct 2018; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20190802001.